gptkbp:instance_of
|
gptkb:biotechnology
|
gptkbp:acquisition
|
Pfizer collaboration
|
gptkbp:awards
|
gptkb:TIME_100_Most_Influential_People_(2021)
|
gptkbp:ceo
|
gptkb:Uğur_Şahin
|
gptkbp:clinical_stage
|
Phase 3
|
gptkbp:clinical_trial
|
gptkb:vaccine
cancer vaccines
influenza vaccine
malaria vaccine
HIV vaccine
Zika virus vaccine
autoimmune disease therapies
TB vaccine
cardiovascular diseases therapies
chronic diseases therapies
infectious diseases therapies
neurodegenerative diseases therapies
rare diseases therapies
vaccine development for emerging diseases
|
gptkbp:collaboration
|
gptkb:Moderna
gptkb:Fosun_Pharma
|
gptkbp:collaborations
|
gptkb:Max_Planck_Institute
gptkb:Harvard_University
gptkb:Johns_Hopkins_University
gptkb:Stanford_University
gptkb:University_of_California
gptkb:University_of_Pennsylvania
gptkb:National_Institutes_of_Health
gptkb:Weill_Cornell_Medicine
gptkb:Yale_University
gptkb:Karolinska_Institute
gptkb:MIT
|
gptkbp:employees
|
over 1,500
|
gptkbp:focus_area
|
m RNA technology
|
gptkbp:founded
|
gptkb:2008
|
gptkbp:founder
|
gptkb:Özlem_Türeci
gptkb:Uğur_Şahin
|
gptkbp:headquarters
|
gptkb:Mainz,_Germany
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bio NTech SE
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
gptkbp:invention
|
m RNA technology patents
|
gptkbp:investment
|
Venture capital
$1.5 billion (2020)
|
gptkbp:market_cap
|
approximately $20 billion
|
gptkbp:notable_products
|
gptkb:BNT162b2
|
gptkbp:partnership
|
gptkb:Sanofi
gptkb:Pfizer
gptkb:Cure_Vac
|
gptkbp:product
|
gptkb:Comirnaty
|
gptkbp:publicly_traded
|
gptkb:NASDAQ
|
gptkbp:research_focus
|
cancer immunotherapy
|
gptkbp:research_institutes
|
gptkb:University_of_Mainz
|
gptkbp:revenue
|
$18.9 billion (2021)
|
gptkbp:stock_symbol
|
gptkb:BNTX
|
gptkbp:subsidiary
|
gptkb:Bio_NTech_RNA_Pharmaceuticals
|
gptkbp:technology
|
lipid nanoparticles
|
gptkbp:vaccine_type
|
gptkb:vaccine
|
gptkbp:website
|
biontech.de
|
gptkbp:bfsParent
|
gptkb:Pfizer-Bio_NTech
gptkb:Frankfurt_Stock_Exchange
gptkb:Bio_NTech
|
gptkbp:bfsLayer
|
5
|